Terms: = Prostate cancer AND CBLB, DKFZp686J10223, 868, ENSG00000114423, Nbla00127, RNF56, FLJ41152, FLJ36865, DKFZp779F1443, DKFZp779A0729
70 results:
1. Diagnostic accuracy of qualitative and quantitative magnetic resonance imaging-guided contrast-enhanced ultrasound (MRI-guided CEUS) for the detection of prostate cancer: a prospective and multicenter study.
Liu Y; Lu D; Xu G; Wang S; Zhou B; Zhang Y; Ye B; Xiang L; Zhang Y; Xu H
Radiol Med; 2024 Apr; 129(4):585-597. PubMed ID: 38512615
[TBL] [Abstract] [Full Text] [Related]
2. PI-RADS v2.1 and PSAD for the prediction of clinically significant prostate cancer among patients with PSA levels of 4-10 ng/ml.
Wen J; Liu W; Shen X; Hu W
Sci Rep; 2024 Mar; 14(1):6570. PubMed ID: 38503972
[TBL] [Abstract] [Full Text] [Related]
3. Impact of urinary diversion type on urethral recurrence following radical cystectomy for bladder cancer: propensity score matched and weighted analyses of retrospective cohort.
Yu J; Lee CU; Chung JH; Song W; Kang M; Jeon HG; Jeong BC; Seo SI; Jeon SS; Sung HH
Int J Surg; 2024 Feb; 110(2):700-708. PubMed ID: 38000052
[TBL] [Abstract] [Full Text] [Related]
4. Assessing the correlation between second progression-free survival (PFS2) and overall survival (OS) in advanced prostate cancer patients using medical data vision (MDV) claims database in Japan.
Shiota M; De Moor R; Koroki Y; Yu DY; Wu DB
Curr Med Res Opin; 2022 Aug; 38(8):1351-1359. PubMed ID: 35770513
[TBL] [Abstract] [Full Text] [Related]
5. Integrative analysis of clinical and epigenetic biomarkers of mortality.
Huan T; Nguyen S; Colicino E; Ochoa-Rosales C; Hill WD; Brody JA; Soerensen M; Zhang Y; Baldassari A; Elhadad MA; Toshiko T; Zheng Y; Domingo-Relloso A; Lee DH; Ma J; Yao C; Liu C; Hwang SJ; Joehanes R; Fornage M; Bressler J; van Meurs JBJ; Debrabant B; Mengel-From J; Hjelmborg J; Christensen K; Vokonas P; Schwartz J; Gahrib SA; Sotoodehnia N; Sitlani CM; Kunze S; Gieger C; Peters A; Waldenberger M; Deary IJ; Ferrucci L; Qu Y; Greenland P; Lloyd-Jones DM; Hou L; Bandinelli S; Voortman T; Hermann B; Baccarelli A; Whitsel E; Pankow JS; Levy D
Aging Cell; 2022 Jun; 21(6):e13608. PubMed ID: 35546478
[TBL] [Abstract] [Full Text] [Related]
6. Cost-effectiveness of enzalutamide versus apalutamide versus androgen deprivation therapy alone for the treatment of metastatic castration-sensitive prostate cancer in Canada.
Saad F; Chilelli A; Hui B; Muratov S; Ganguli A; North S; Shayegan B
J Med Econ; 2022; 25(1):583-590. PubMed ID: 35469527
[TBL] [Abstract] [Full Text] [Related]
7. Non-prostate cancer tumours: incidence on
Perry E; Talwar A; Sharma S; O'Connor D; Wong LM; Taubman K; Sutherland TR
Eur J Nucl Med Mol Imaging; 2022 Jul; 49(9):3277-3288. PubMed ID: 35254481
[TBL] [Abstract] [Full Text] [Related]
8. Artificial intelligence for diagnosis and Gleason grading of prostate cancer: the PANDA challenge.
Bulten W; Kartasalo K; Chen PC; Ström P; Pinckaers H; Nagpal K; Cai Y; Steiner DF; van Boven H; Vink R; Hulsbergen-van de Kaa C; van der Laak J; Amin MB; Evans AJ; van der Kwast T; Allan R; Humphrey PA; Grönberg H; Samaratunga H; Delahunt B; Tsuzuki T; Häkkinen T; Egevad L; Demkin M; Dane S; Tan F; Valkonen M; Corrado GS; Peng L; Mermel CH; Ruusuvuori P; Litjens G; Eklund M;
Nat Med; 2022 Jan; 28(1):154-163. PubMed ID: 35027755
[TBL] [Abstract] [Full Text] [Related]
9. Androgen deprivation therapy and acute kidney injury in patients with prostate cancer undergoing definitive radiotherapy.
Sherer MV; Deka R; Salans MA; Nelson TJ; Sheridan P; Rose BS
Prostate Cancer Prostatic Dis; 2023 Jun; 26(2):276-281. PubMed ID: 34811501
[TBL] [Abstract] [Full Text] [Related]
10. The efficacy and tolerability of ultra-hypofractionated radiotherapy in low-intermediate risk prostate cancer patients: single center experience.
Dinçer S; Uysal E; Berber T; Akboru MH
Aging Male; 2021 Dec; 24(1):50-57. PubMed ID: 34233569
[TBL] [Abstract] [Full Text] [Related]
11. Concomitant intraductal carcinoma of the prostate and response to hormonal therapy in metastatic prostate carcinoma.
Abascal-Junquera JM; Fumadó-Ciutat L; Gasa-Galmes B; Costa-Planells M; Munarriz-Polo M; Sanromà-Salvà A; Polaina-Barroso L; Solà-Marqués C; Juanpere-Rodero N; Lloreta-Trull J; Cecchini-Rosell L
Actas Urol Esp (Engl Ed); 2021; 45(6):455-460. PubMed ID: 34147428
[TBL] [Abstract] [Full Text] [Related]
12. Identification of a five gene signature to predict time to biochemical recurrence after radical prostatectomy.
Corradi JP; Cumarasamy CW; Staff I; Tortora J; Salner A; McLaughlin T; Wagner J
Prostate; 2021 Jul; 81(10):694-702. PubMed ID: 34002865
[TBL] [Abstract] [Full Text] [Related]
13. Identification of a novel non-invasive biological marker to overcome the shortcomings of PSA in diagnosis and risk stratification for prostate cancer: Initial prospective study of developmental endothelial locus-1 protein.
Chung JW; Kim HT; Ha YS; Lee EH; Chun SY; Lee CH; Byeon KH; Choi SH; Lee JN; Kim BS; Kim TH; Yoo ES; Yoon GS; Baek MC; Kwon TG
PLoS One; 2021; 16(4):e0250254. PubMed ID: 33901217
[TBL] [Abstract] [Full Text] [Related]
14. Androgen Receptor Binding Category Prediction with Deep Neural Networks and Structure-, Ligand-, and Statistically Based Features.
García-Sosa AT
Molecules; 2021 Feb; 26(5):. PubMed ID: 33652992
[TBL] [Abstract] [Full Text] [Related]
15. Quality of Life After Bladder cancer: A Cross-sectional Survey of Patient-reported Outcomes.
Catto JWF; Downing A; Mason S; Wright P; Absolom K; Bottomley S; Hounsome L; Hussain S; Varughese M; Raw C; Kelly P; Glaser AW
Eur Urol; 2021 May; 79(5):621-632. PubMed ID: 33581875
[TBL] [Abstract] [Full Text] [Related]
16. Prostatic ductal adenocarcinoma variant predicts worse pathological and oncological outcomes: Insight from over 1000 consecutive patients from a large prospective uro-oncology registry.
Tan YG; Khalid F; Huang HH; Chen K; Tay KJ; Lau WKO; Cheng CWS; Ngo NT; Yuen JSP
Prostate; 2021 Mar; 81(4):242-251. PubMed ID: 33428259
[TBL] [Abstract] [Full Text] [Related]
17. Preoperative Inflammation Markers in Predicting Biochemical Recurrence after Robot-assisted Radical prostatectomy.
Olcucu MT; Karamik K; Yilmaz K; Ozsoy C; Aktas Y; Ates M
J Coll Physicians Surg Pak; 2020 Sep; 30(9):921-927. PubMed ID: 33036675
[TBL] [Abstract] [Full Text] [Related]
18. [Necessity of Pelvic Drain Placement after Robot-Assisted Radical prostatectomy].
Makita N; Kubota M; Murata S; Suzuki I; Tohi Y; Sugino Y; Inoue K; Kawakita M
Hinyokika Kiyo; 2020 Sep; 66(9):283-287. PubMed ID: 32993271
[TBL] [Abstract] [Full Text] [Related]
19. Implication of Prophetic Variables and their Impulsive Interplay in CA prostate Patients Experiencing Osteo-Metastasis.
Ashraf MAB; Zahid A; Ashraf S; Waquar S; Iqbal S; Malik A
Anticancer Agents Med Chem; 2020; 20(17):2106-2113. PubMed ID: 32718298
[TBL] [Abstract] [Full Text] [Related]
20. Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases.
Ishigaki K; Akiyama M; Kanai M; Takahashi A; Kawakami E; Sugishita H; Sakaue S; Matoba N; Low SK; Okada Y; Terao C; Amariuta T; Gazal S; Kochi Y; Horikoshi M; Suzuki K; Ito K; Koyama S; Ozaki K; Niida S; Sakata Y; Sakata Y; Kohno T; Shiraishi K; Momozawa Y; Hirata M; Matsuda K; Ikeda M; Iwata N; Ikegawa S; Kou I; Tanaka T; Nakagawa H; Suzuki A; Hirota T; Tamari M; Chayama K; Miki D; Mori M; Nagayama S; Daigo Y; Miki Y; Katagiri T; Ogawa O; Obara W; Ito H; Yoshida T; Imoto I; Takahashi T; Tanikawa C; Suzuki T; Sinozaki N; Minami S; Yamaguchi H; Asai S; Takahashi Y; Yamaji K; Takahashi K; Fujioka T; Takata R; Yanai H; Masumoto A; Koretsune Y; Kutsumi H; Higashiyama M; Murayama S; Minegishi N; Suzuki K; Tanno K; Shimizu A; Yamaji T; Iwasaki M; Sawada N; Uemura H; Tanaka K; Naito M; Sasaki M; Wakai K; Tsugane S; Yamamoto M; Yamamoto K; Murakami Y; Nakamura Y; Raychaudhuri S; Inazawa J; Yamauchi T; Kadowaki T; Kubo M; Kamatani Y
Nat Genet; 2020 Jul; 52(7):669-679. PubMed ID: 32514122
[TBL] [Abstract] [Full Text] [Related]
[Next]
